227 related articles for article (PubMed ID: 24961898)
21. The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.
Balzarini J; Liekens S; Esnouf R; De Clercq E
Biochemistry; 2002 May; 41(20):6517-24. PubMed ID: 12009916
[TBL] [Abstract][Full Text] [Related]
22. A new nucleoside analogue with potent activity against mutant sr39 herpes simplex virus-1 (HSV-1) thymidine kinase (TK).
Sundaram GS; Harpstrite SE; Kao JL; Collins SD; Sharma V
Org Lett; 2012 Jul; 14(14):3568-71. PubMed ID: 22765027
[TBL] [Abstract][Full Text] [Related]
23. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
Koyano S; Suzutani T; Yoshida I; Azuma M
Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
[TBL] [Abstract][Full Text] [Related]
24. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
[TBL] [Abstract][Full Text] [Related]
25. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK
Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
[TBL] [Abstract][Full Text] [Related]
27. In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase.
Mahalingam R; Cabirac G; Wellish M; Gilden D; Vafai A
Virus Genes; 1990 Jul; 4(2):105-20. PubMed ID: 1698324
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Ativiral Activity of 5-(Benzylthio)-4-carbamyl-1,2,3-triazoles Against Human Cytomegalovirus (CMV) and Varicella-zoster Virus (VZV).
Wen YN; Zhang ZF; Liu NN; Andrei G; Snoeck R; Xiang YH; Schols D; Chen X; Zhang ZY; Zhang QS; Wu QP
Med Chem; 2017; 13(5):453-464. PubMed ID: 28290250
[TBL] [Abstract][Full Text] [Related]
29. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.
Chiba A; Suzutani T; Saijo M; Koyano S; Azuma M
Acta Virol; 1998 Dec; 42(6):401-7. PubMed ID: 10358747
[TBL] [Abstract][Full Text] [Related]
30. Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication.
Balzarini J; McGuigan C
J Antimicrob Chemother; 2002 Jul; 50(1):5-9. PubMed ID: 12096000
[TBL] [Abstract][Full Text] [Related]
31. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
32. QSAR and molecular graphics analysis of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases.
Gaudio AC; Richards WG; Takahata Y
J Mol Graph Model; 2000 Feb; 18(1):33-41. PubMed ID: 10935205
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses.
Sekiyama T; Hatsuya S; Tanaka Y; Uchiyama M; Ono N; Iwayama S; Oikawa M; Suzuki K; Okunishi M; Tsuji T
J Med Chem; 1998 Apr; 41(8):1284-98. PubMed ID: 9548818
[TBL] [Abstract][Full Text] [Related]
34. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.
Degrève B; Johansson M; De Clercq E; Karlsson A; Balzarini J
J Virol; 1998 Dec; 72(12):9535-43. PubMed ID: 9811686
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of A-73209, a potent orally active agent against VZV and HSV infections.
Alder J; Mitten M; Norbeck D; Marsh K; Kern ER; Clement J
Antiviral Res; 1994 Feb; 23(2):93-105. PubMed ID: 8147583
[TBL] [Abstract][Full Text] [Related]
36. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
Nitta K; Shiota H; Naito T; Mimura Y
Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
[TBL] [Abstract][Full Text] [Related]
37. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
38. Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase.
Kussmann-Gerber S; Kuonen O; Folkers G; Pilger BD; Scapozza L
Eur J Biochem; 1998 Jul; 255(2):472-81. PubMed ID: 9716390
[TBL] [Abstract][Full Text] [Related]
39. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
40. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
